← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...
HomeStocksSLXNWPrice History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

Silexion Therapeutics Ltd. (SLXNW) Stock Price History

Historical prices from 2024 to 2026

Current Price
$0.03
-0.00 (-8.99%)
All-Time High
$0.18
Aug 12, 2024
-80.9% from ATH
All-Time Low
$0.01
Dec 12, 2024
Avg Volume (50D)
49K
Daily average
52-Week Range$0.02 — $0.09
LowCurrent: $0.03High

Loading 10-year price history...

Historical Performance

1 YearTotal Return
-42.7%
Price: -42.7%
3 YearsTotal Return
-79.8%
CAGR: -41.3%
Price: -79.8%
5 YearsTotal Return
-79.8%
CAGR: -27.4%
Price: -79.8%
YTD
+32.3%

Short-Term Returns

1D-9.0%
1W-9.0%
1M-12.2%
3M+14.3%
6M+1.8%

Download Historical Data

316 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

SLXNW Stock Price Trajectory (2024–2026)

As of February 28, 2026, Silexion Therapeutics Ltd. (SLXNW) trades at $0.03, representing a -42.7% return over the past year. The stock has delivered a -27.4% return over five years, reflecting challenging market conditions.

The stock reached its all-time high of $0.18 on August 12, 2024. From this peak, SLXNW has corrected -80.9%, currently trading 18% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers ALNY (+34.9% 1Y), IONS (+144.5% 1Y), and ARWR (+234.6% 1Y), SLXNW has underperformed the peer group average. Compare SLXNW vs ALNY →

Historical Price Data

Showing 30 of 316 records
Date Open High Low Close Volume Change %
2026-02-250.030.040.030.030-8.99%
2026-02-230.030.040.030.040+8.00%
2026-02-200.030.040.030.0400.00%
2026-02-190.030.040.030.04900+7.36%
2026-02-130.030.030.030.03788+20.74%
2026-02-120.030.030.030.03900-29.50%
2026-02-100.030.040.040.041K+11.34%
2026-02-060.030.040.030.0331K-1.71%
2026-02-050.030.040.040.0429K-0.28%
2026-02-040.030.040.040.04103K-17.22%
2026-02-030.030.040.040.042K+10.42%
2026-01-310.030.040.040.0417K+3.78%
2026-01-300.030.040.040.047K-5.13%
2026-01-290.030.040.040.0418K-0.51%
2026-01-280.030.040.040.0410K-1.26%
2026-01-260.030.040.040.041K+13.11%
2026-01-240.030.040.040.048K+0.29%
2026-01-230.030.040.040.0413K-11.39%
2026-01-220.030.040.040.043K+12.86%
2026-01-200.030.040.040.0432K-5.41%
2026-01-170.030.040.030.0413K-6.33%
2026-01-160.030.040.040.041K+12.86%
2026-01-150.030.040.040.043K-0.57%
2026-01-130.030.040.030.04110K-11.56%
2026-01-120.030.040.040.041K+4.74%
2026-01-100.030.040.030.04142K-4.04%
2026-01-080.030.040.030.045K+32.00%
2026-01-070.030.040.030.03748-24.05%
2026-01-060.030.040.030.0414K+1.28%
2026-01-030.030.050.020.0447K+50.00%

See SLXNW's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is SLXNW Undervalued?

See our Bear / Base / Bull DCF models and intrinsic value estimates.

View Valuation

Compare SLXNW vs AGIO

See how SLXNW stacks up against sector leader Agios Pharmaceuticals, Inc..

Start Comparison

Frequently Asked Questions

How has SLXNW stock performed recently?

SLXNW declined -42.7% over the past year, below its 5-year annualized CAGR of -27.4%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is SLXNW's all-time high price?

Silexion Therapeutics Ltd. reached $0.18 on 2024-08-12. The 52-week high is $0.09. Current 1-year return of -42.7% places the stock further from historical peaks.

Where can I download SLXNW historical price data?

This page provides SLXNW daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2024-2026, downloadable in CSV format.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.
Showing 316 data points